United Therapeutics Corp.
(NASDAQ : UTHR)

( )
UTHR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 0.00%68.905.6%$176.24m
CTLTCatalent, Inc. 0.03%94.682.1%$118.97m
VRXValeant Pharmaceuticals International, Inc. 0.05%19.1814.1%$112.86m
BHCBausch Health Cos., Inc. 0.05%19.180.0%$84.61m
JAZZJazz Pharmaceuticals Plc 0.00%141.832.4%$80.64m
GWPHGW Pharmaceuticals Plc 0.00%127.616.1%$68.14m
UTHRUnited Therapeutics Corp. 0.00%135.0714.1%$62.12m
PRGOPerrigo Co. Plc -0.04%47.916.8%$57.46m
SAGESAGE Therapeutics, Inc. 0.00%82.708.6%$45.76m
ARGXargenx SE 0.00%265.480.0%$38.82m
SAVACassava Sciences, Inc. 0.00%7.700.0%$38.44m
ICLRICON plc 0.00%188.254.2%$37.20m
AMRNAmarin Corp. Plc 0.00%4.601.5%$35.78m
BLRXBioLineRx Ltd. 0.00%2.251.8%$34.57m
ICPTIntercept Pharmaceuticals, Inc. 0.00%37.3916.8%$32.74m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.